Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Gross Margin
Dhg Pharmaceutical Joint-Stock Co
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
VN |
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
12.7T VND |
44%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
838.1B USD |
81%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
372.1B USD |
68%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
85%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
210.1B CHF |
74%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
188.1B CHF |
75%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
162.5B GBP |
82%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
209.1B USD |
79%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
68%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
116.5B EUR |
70%
|
Dhg Pharmaceutical Joint-Stock Co
Glance View
DHG Pharmaceutical JSC engages in the production, sale, and trade of pharmaceutical products. The company is headquartered in Can Tho, Can Tho and currently employs 2,770 full-time employees. The company went IPO on 2006-12-21. The firm manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Dhg Pharmaceutical Joint-Stock Co's most recent financial statements, the company has Gross Margin of 43.8%.